March 2026 - Laimaa Fertility Healthcare

Laimaa Fertility Healthcare

March 2026

IVF Failure to Success: Role of an Embryologist

From IVF Failure to Success: When an Embryologist Makes a Difference

In most in vitro fertilisation (IVF) conversations, the doctor becomes the centre of attention. Patients remember the consultation room, the ultrasound screen, the trigger date, and the result call. Very rarely, they remember the laboratory. Even more rarely, they remember the person who spends six to eight hours with their embryos, often longer than anyone else involved in the treatment. Yet, when IVF fails again and again, the reason is very often not in the consultation room. It is hidden in a series of very small, silent choices made inside the lab. These choices are not dramatic. They do not look like mistakes. They look like routine. This is where the embryologist quietly changes the story. IVF was first made possible through the work of Robert G. Edwards, but what most people forget is that his real contribution was not a machine or a drug. It was laboratory thinking. Modern IVF is still, in many ways, a laboratory discipline more than a clinical one. And yet, we still talk about IVF failure almost entirely in clinical language: hormones,  age, ovarian reserve, uterus, and endometrium. Very little is said about how the embryo was handled, observed, disturbed, classified, protected, or quietly compromised. This blog is not about laboratory equipment, incubators, or technology trends. It is about the human being who operates between biology and uncertainty — the embryologist — and how IVF success sometimes depends less on what is done, and more on what is deliberately not done. IVF Does Not Fail Suddenly – It Fails Slowly Most failed IVF cycles do not collapse at one big point. They weaken gradually. An embryo does not usually stop developing because of one dramatic event. It slows down because of accumulated stress. Stress in the lab does not look like stress to patients. It looks like: None of these is a mistake on its own. But embryos respond to accumulation, not to individual events. A skilled embryologist thinks in cumulative damage. This is one of the biggest gaps between an average and an exceptional laboratory professional. The best embryologists are not the most active ones. They are the most restrained ones. Laboratory Confidence Is Not Technical Confidence Many clinics advertise highly advanced labs—very few talk about laboratory judgment. A technician can be trained to perform Intracytoplasmic Sperm Injection (ICSI). A professional embryologist develops a sense of biological timing. There is a difference. These are not clock-based activities. They are embryo-based activities. An embryologist who follows the schedule rigidly may technically do everything correctly and still lose outcomes. An embryologist who learns to adjust workflow around the behaviour of each cohort of oocytes and embryos is practising a different level of laboratory care. This flexibility is not visible in brochures. It is visible only in consistent pregnancy rates in difficult cases. IVF Failure After “Good Quality Embryos” Is Often A Lab Communication Problem Patients are frequently told: “You had good embryos.” This sentence hides a serious limitation. What does “good” mean? Grade. Cell number. Fragmentation. Blastocyst expansion. These parameters describe appearance. They do not describe stability. An embryo that looks excellent can still be metabolically fragile. In many laboratories, the communication between embryologist and clinician is structured around static scoring. But IVF outcomes improve when embryologists communicate something else: behaviour. These behavioural patterns are extremely predictive, but they are rarely included in reports. When an embryologist starts reporting biological behaviour rather than visual grades, clinical decisions change. Transfer strategy changes. Freeze strategy changes. The number of embryos transferred changes. And success rates quietly improve. One Of The Biggest Laboratory Risks Is Emotional Pressure Embryologists work very closely with patient emotions, but patients rarely see them. The calls. The messages. The waiting couples. The visible anxiety. In repeated failure cases, pressure inside the lab increases.  There is a subtle and dangerous shift that can occur: The embryologist begins trying to rescue outcomes. More manipulation. More “fine-tuning”. More checking. More repositioning. More intervention. This comes from empathy, not carelessness. But biology does not reward emotional urgency. A mature embryologist learns—how to protect embryos from human anxiety. This emotional discipline is rarely discussed, but it is one of the reasons some professionals consistently perform better in complex cycles. Also read: Genetic Testing in IVF | PGS & PGD  IVF Failure Is Sometimes A Data Problem, Not A Biology Problem Most laboratories collect large volumes of data. Very few actually analyse it meaningfully. A good embryologist reviews: This is not administrative work. This is biological auditing. When embryologists lead internal outcome analysis rather than leaving it entirely to clinical teams, very small workflow changes produce measurable improvement. IVF success is rarely created by a dramatic change. It is created by small corrections made repeatedly. Why Do Embryologists Make The Biggest Difference In Difficult Cases Easy cases succeed almost anywhere. Young patients. High oocyte yield. Good sperm. Predictable response. In such cycles, even average laboratory practice may achieve good results. The real value of a highly skilled embryologist appears in difficult biology: In these cases, each oocyte carries disproportionate emotional and clinical value. Handling becomes more careful. Timing becomes more individualised. Selection becomes more behaviour-driven. This is where professional maturity shows. Final Thoughts IVF marketing often focuses on machines, numbers and promises. Real improvement happens quietly. It happens when an embryologist pauses before intervening. It happens when an embryo is left undisturbed for one more hour. It happens when a fragile blastocyst is not pushed into transfer simply to meet expectations. It happens when laboratory teams review failures without blame. From failure to success, the turning point is very often not a new protocol. It is a different way of thinking inside the lab. And that way of thinking belongs, more than anyone else, to the embryologist. At Laimaa Healthcare, this laboratory mindset plays a central role in how IVF cycles are reviewed, refined, and improved for patients who have experienced previous failures.

From IVF Failure to Success: When an Embryologist Makes a Difference Read More »

Immune Testing & IVF Failure: What Patients Should Know

Can Immune Testing Predict IVF Failure?

At Laimaa Healthcare, fertility specialists often meet couples who ask whether immune testing can explain repeated IVF failure. In the last few years, immune testing has quietly entered fertility clinics—not with loud promises, but with soft reassurance. A blood test here, a panel there, and a suggestion that maybe the immune system is the hidden reason behind repeated IVF failure. Patients rarely come asking for immune tests on day one. They come after two failed transfers—sometimes after three. Often, after they have already done everything that standard IVF medicine advises. At that moment, immune testing looks attractive. It looks scientific. It looks like progress. But the real question is not whether immune testing can detect something abnormal. The real question is: Can immune testing actually predict IVF failure in a way that changes the outcome? The Uncomfortable Reality About IVF Failure Most IVF failures are still explained by only two large factors: Even today, after advanced genetics, better culture systems and improved stimulation protocols, implantation remains inefficient. And when no obvious problem appears in scans, hormone levels or embryo reports, the word “immune” quietly enters the discussion. Not because the immune system is irrelevant. But because it is complex, powerful and poorly measurable inside the uterus. The First Problem: What Exactly Is “Immune Testing” In IVF? There is no single immune test. In routine fertility practice, immune testing usually refers to combinations of: The problem is not that these tests exist. The problem is that they are borrowed from autoimmune and transplant medicine and placed into reproductive medicine without strong validation for implantation failure. That difference is not small. It changes everything. Blood Immunity And Uterine Immunity Are Not The Same System This is rarely explained clearly to patients. Most immune tests are done on blood. Implantation, however, happens inside a very specialised tissue – the endometrium. The immune cells that matter most during implantation are: Peripheral blood NK cells behave very differently from uterine NK cells. They have different surface markers. They respond to different signals. They perform different functions. So when a report shows “high NK activity” in blood, it does not directly tell what is happening at the embryo–endometrium interface. This gap is not small. It is biological. Why Immune Testing Feels Convincing After Repeated Failures Repeated failure changes the psychology of treatment. After several good-quality embryos fail to implant, patients and clinicians both want a new explanation. Immune testing offers something that routine IVF evaluation cannot: A new variable. Not necessarily a correct one, but a new one. And new variables feel like progress. But Prediction Is Different From Explanation This is where the discussion must become honest. Immune testing is often presented as: “Let us see whether immunity is the reason for failure.” But the patient really wants something else: can this test tell me whether my next IVF will fail? That is a prediction. And this is where immune testing performs poorly. The Biggest Weakness: Immune Markers Are Unstable One of the least discussed problems is biological variability. Immune markers change with: A patient can test “high” today and “normal” next month without any intervention. Yet clinical decisions are sometimes taken based on a single snapshot. This makes the prediction unreliable. IVF Failure Is Not An Immune Event Alone Implantation is not a simple accept–reject mechanism. It is a synchronised process involving: The immune system does not initiate implantation. It fine-tunes it. When something fails, immune disturbance may be a downstream effect rather than the primary cause. This distinction is critical. Can Immune Testing Ever Predict IVF Failure? If we answer strictly and clinically: No immune test today can reliably predict IVF failure in an individual patient. Not with the accuracy that justifies routine use. Not with reproducibility across populations. Not with validated thresholds. But Is Immune Involvement Completely Irrelevant? No. That would also be incorrect. There are limited situations where immune evaluation is relevant: In these contexts, the immune issue is already clinically evident. It is not discovered through screening panels done only for IVF. The Confusion Between Miscarriage And Implantation Failure Another important misunderstanding. Most immune research is stronger in pregnancy loss, not implantation failure. These are biologically different stages. The immune mechanisms that maintain an established placenta are not identical to those involved in early attachment. Yet many immune tests are marketed for implantation failure using evidence from miscarriage populations. This is a serious extrapolation problem. A Better Way To Look At Unexplained IVF Failure From a modern clinical angle, unexplained failure is increasingly viewed as: These areas, although less dramatic than immune theory, consistently show stronger links to outcome. Also read: Low Egg Count: Can I Still Get Pregnant?  Where Research Is Actually Moving Interestingly, serious research is not focused on peripheral immune panels. It is moving towards: These approaches aim to understand micro-environmental communication rather than broad systemic immunity. But none of this is clinically deployable yet. Prediction models based on these technologies are still under development. The Commercialisation Risk Immune testing has entered a difficult space. It remains between: Patients often assume that if a test is offered, it must be validated for that purpose. In reality, laboratory availability does not equal clinical validity. So, what is the correct role of immune testing today? At present, immune testing should be: It should not be positioned as a standard next step after two failed transfers. Conclusion  At Laimaa Healthcare, the focus remains on evidence-based fertility treatment, personalised IVF planning, and improving cumulative success rates rather than relying on poorly predictive immune panels. IVF medicine is already complex. Adding poorly predictive tools increases complexity without improving clarity. The focus should remain on cumulative success strategies, laboratory excellence, embryo competence assessment, and patient-specific stimulation and transfer planning. Until immune science moves from associative findings to precise, targetable mechanisms at the implantation site, immune testing will remain more exploratory than predictive. That distinction matters. For patients investing emotionally, physically and financially into every cycle, what matters most is not whether a

Can Immune Testing Predict IVF Failure? Read More »